Holen Sie sich die Stockscreener-App
19.05
0.85%
0.16
Handel nachbörslich:
19.05
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$18.89
Offen:
$19.02
24-Stunden-Volumen:
1.44M
Relative Volume:
1.00
Marktkapitalisierung:
$2.85B
Einnahmen:
$5.75B
Nettoeinkommen (Verlust:
$77.00M
KGV:
-9.4776
EPS:
-2.01
Netto-Cashflow:
$-675.00M
1W Leistung:
-3.84%
1M Leistung:
-3.05%
6M Leistung:
-34.06%
1J Leistung:
-30.17%
1-Tages-Spanne:
$18.79
$19.16
1-Wochen-Bereich:
$18.77
$19.73
52-Wochen-Spanne:
$15.10
$32.70
Chemours Company Stock (CC) Company Profile
Firmenname
Chemours Company
Sektor
Branche
Telefon
302 773 1000
Adresse
1007 MARKET STREET, WILMINGTON, DE
Vergleichen Sie CC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CC | 19.05 | 2.85B | 5.75B | 77.00M | -675.00M | -2.01 |
| LIN | 448.57 | 212.87B | 33.03B | 6.38B | 4.94B | 12.11 |
| SHW | 375.35 | 95.64B | 23.05B | 2.56B | 2.05B | 9.34 |
| APD | 327.89 | 72.30B | 12.10B | 3.83B | -3.15B | 9.83 |
| ECL | 245.97 | 69.76B | 15.67B | 2.04B | 2.00B | 4.31 |
| DD | 81.89 | 34.23B | 12.19B | 799.00M | 1.24B | 9.66 |
Chemours Company Stock (CC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-06-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-01-24 | Hochstufung | UBS | Neutral → Buy |
| 2023-01-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-01-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-01 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-13 | Eingeleitet | Goldman | Neutral |
| 2022-10-05 | Herabstufung | Argus | Buy → Hold |
| 2022-06-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-06-10 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-09 | Hochstufung | Goldman | Neutral → Buy |
| 2021-05-20 | Eingeleitet | BofA Securities | Buy |
| 2021-05-06 | Hochstufung | Argus | Hold → Buy |
| 2021-01-08 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-12-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-11-30 | Eingeleitet | Alembic Global Advisors | Overweight |
| 2020-03-23 | Herabstufung | Jefferies | Buy → Hold |
| 2020-02-14 | Hochstufung | CFRA | Buy → Strong Buy |
| 2019-11-06 | Hochstufung | CFRA | Hold → Buy |
| 2019-08-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2019-08-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-08-06 | Herabstufung | Argus | Buy → Hold |
| 2019-08-05 | Herabstufung | SunTrust | Buy → Hold |
| 2019-07-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-04-15 | Hochstufung | SunTrust | Hold → Buy |
| 2019-02-19 | Herabstufung | Susquehanna | Positive → Neutral |
| 2019-01-08 | Eingeleitet | HSBC Securities | Buy |
| 2019-01-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-11-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-07-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2018-01-30 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-12-06 | Herabstufung | Goldman | Buy → Neutral |
| 2017-08-07 | Hochstufung | UBS | Sell → Neutral |
Alle ansehen
Chemours Company Aktie (CC) Neueste Nachrichten
Vaughan Nelson Investment Management L.P. Sells 657,560 Shares of The Chemours Company (NYSE:CC) - MarketBeat
State of New Jersey Common Pension Fund D Increases Holdings in The Chemours Company (NYSE:CC) - MarketBeat
Chemours Titanium Technologies Announces Fourth Annual Carrier Of The Year Award - Coatings World
Chemours China Hosts the 8th Annual Magical Science Camp Supporting Youth Exploration of STEM - ReportAlert.info
Chemours sets pricing for $600 million senior notes By Investing.com - Investing.com Australia
Chemours changes course on hydrogen investment - Delaware Business Times
CC (The Chemours Co) EBITDA per Share : $4.04 (TTM As of Sep. 2024) - GuruFocus.com
(CC)Analyzing Chemours's Short Interest - Benzinga
CC (The Chemours Co) Depreciation, Depletion and Amortizati - GuruFocus.com
The Chemours Company priced private offering of 8.000% senior notes due 2033 - MSN
The Chemours Company Announces Pricing of Private Offering of $600,000,000 of 8.000% Senior Notes Due 2033 - Marketscreener.com
Chemours sets pricing for $600 million senior notes - Investing.com India
Chemours Prices $600M Senior Notes at 8% to Refinance Euro Debt | CC Stock News - StockTitan
Chemours' Earnings and Revenues Surpass Estimates in Q3 - MSN
Ex-Dividend Reminder: Chemours, Arch Resources and CONSOL Energy - Nasdaq
Chemours to issue $600 million in senior notes due 2033 - Investing.com
Chemours to issue $600 million in senior notes due 2033 By Investing.com - Investing.com UK
Chemours Titanium Technologies Announces Fourth Annual Carrier of the Year Award - ReportAlert.info
Chemours Launches $600M Senior Notes Offering to Refinance Euro Debt | CC Stock News - StockTitan
GSA Capital Partners LLP Acquires New Shares in The Chemours Company (NYSE:CC) - MarketBeat
[Latest] Global Foaming Agent Market Size/Share Worth USD 2,855.9 Million by 2033 at a 4.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.
FMR LLC Increases Stake in The Chemours Co - GuruFocus.com
The Chemours Company's SWOT analysis: TiO2 giant faces drought, cost cuts - Investing.com
Chemours' (NYSE:CC) Earnings Offer More Than Meets The Eye - Simply Wall St
Why Chemours' (NYSE:CC) Earnings Are Better Than They Seem - Yahoo Finance
Electronic Grade Titanium Tetrachloride Market Anticipated - openPR
The Chemours Company (NYSE:CC) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Chemours's stock jumps on quarterly revenue growth - MSN
YieldBoost Chemours From 4.9% To 20.5% Using Options - Nasdaq
Chemours earnings surpass forecasts - delawarebusinessnow.com
Chemours Washington Works Nature Trail Dedicates Outdoor Classroom to U.S. Senator Joe Manchin, III - CSRwire.com
Chemours (NYSE:CC) Posts Quarterly Earnings Results, Beats Expectations By $0.08 EPS - MarketBeat
Morgan Stanley Issues Pessimistic Forecast for Chemours (NYSE:CC) Stock Price - MarketBeat
Chemours (NYSE:CC) Price Target Raised to $23.00 at Barclays - MarketBeat
What Analysts Are Saying About Chemours Stock - Benzinga
The Chemours Company (NYSE:CC) Q3 2024 Earnings Call Transcript - Insider Monkey
Chemours price target lowered to $25 from $30 at Morgan Stanley - TipRanks
Chemours Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Chemours price target raised to $23 from $21 at Barclays - TipRanks
Should You Investigate The Chemours Company (NYSE:CC) At US$20.58? - Yahoo Finance
The Chemours Co (CC) Q3 2024 Earnings Call Highlights: Navigatin - GuruFocus.com
The Chemours Co (CC) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
Earnings call: Chemours reports modest growth with strategic focus By Investing.com - Investing.com Nigeria
Chemours Reports Q3 2024 Results and Strategic Update - TipRanks
Chemours (CC) Stabilizes with Strong Q3 Results and Record Sales in TSS Segment - GuruFocus.com
Earnings call: Chemours reports modest growth with strategic focus - Investing.com
Chemours (CC) Q3 2024 Earnings Call Transcript - The Motley Fool
Chemours Surges 17% On The Recent Q3 Results - GuruFocus.com
Chemours (NYSE:CC) Shares Gap UpWhat's Next? - MarketBeat
The Chemours Co (CC) Stock Price Up 16.44% on Nov 4 - GuruFocus.com
Update: Chemours halts $200m hydrogen membrane manufacturing expansion - H2 View
Finanzdaten der Chemours Company-Aktie (CC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):